The DOI matches its Crossref record.
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nitrite metabolism can be activated by hypoxia, low pH and reactions with metalloproteins[50–58].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [50]
Citations
Cited by
Sorted by citations
Items 901–999 of 999
Ma, S., Ignarro, L. J., Byrns, R. E., & Li, X.-Y. (1999) · Nitric Oxide · doi:10.1006/niox.1999.0218 · Cited by 19
Self-citationOmar, H. A., Gong, F., Sun, M., et al. (1999) · PubMed · Cited by 19
[24] Fluorometric detection of S-nitrosothiols
Kostka, P., & Park, J. K. J. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)01086-1 · Cited by 19
Durand, Mucci, SAFONT, & PREFAUT (1999) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1999.00480.x · Cited by 19
Tsutamoto, T., Kinoshita, M., 久永, 智., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80750-4 · Cited by 19
Ahlner, J., Axelsson, K. L., Ekstram‐Ljusegren, M., et al. (1988) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1988.tb01864.x · Cited by 19
Ljusegren, M. E., & Axelsson, K. L. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01339.x · Cited by 17
Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?
Arrigo, E., Comità, S., Pagliaro, P., Penna, C. R. R., & Mancardi, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512480 · Cited by 21
Synthesis and characterization of carnitine nitro-derivatives
Piermatti, O., Fringuelli, F., Pochini, L., Indiveri, C., & Palmerini, C. A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.053 · Cited by 18
Polymeric Antioxidant Materials for Treatment of Inflammatory Disorders
Yeo, J., Lee, J., 이상기, & Kim, W. J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000270 · Cited by 20
The role of organic nitrates in the treatment of heart failure
Elkayam, U., Karaalp, I. S., Wani, O. R., Tummala, P. P., & Akhter, M. W. (1999) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.1999.0410255 · Cited by 18
Synthesis, Decomposition, and Vasodilator Action of Some New S-Nitrosated Dipeptides
Butler, A. R., Al‐Sa'doni, H. H., Megson, I. L., & Flitney, F. W. (1998) · Nitric Oxide · doi:10.1006/niox.1998.0172 · Cited by 18
Synthesis of novel organic nitrate esters: guanylate cyclase activation and tissue relaxation
Yang, K., Artz, J. D., Lock, J. D., et al. (1996) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19960001073 · Cited by 18
Cook, A. M., & Haynes, J. M. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.09.003 · Cited by 18
Nonglycemic effects of insulin
Yki‐Järvinen, H. (2003) · Clinical cornerstone · doi:10.1016/s1098-3597(03)90061-5 · Cited by 17
“Release of NO from the endothelium induces vasorelaxation of adjacent smooth muscle cells via stimulation of guanylate cyclase (Figure 4) (16).”
BackgroundN‐Nitrosomelatonin: synthesis, chemical properties, potential prodrug
Kirsch, M., & de GROOT, H. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00655.x · Cited by 19
Yi, J., Khan, M. A., Lee, J., & Richter-Addo, G. B. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.03.005 · Cited by 18
“[16,17] proposed that the biological action of vasodilators such as organic nitrates, nitrites, and nitroprusside could be attributed, in part, to the intermediacy of unstable S-nitroso compounds.”
BackgroundBoer, C., van der Linden, P. J. W., Scheffer, G. J., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00093.2001 · Cited by 18
“An increased concentration of acetylcholine induces more endothelial Ca2 influx and therefore activates more endothelial NO synthase (NO synthase III) molecules, resulting in an increased NO release (8).”
BackgroundKurjak, M., Koppitz, P. B., SCHUSDZIARRA, V., et al. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.4.g875 · Cited by 18
“Because SIN-1 was less potent in relaxing smooth muscle and generating NO than SNAP, but similarly effective in inhibiting NOS, it was suggested that even small amounts of NO present elicit significant NOS inhibition or that additional mechanisms not related to free NO might play a role (23).”
BackgroundKojda, G. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00268-x · Cited by 18
Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris
Metelitsa, V. I., Martsevich, S. Y., Козырева, М. П., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90222-k · Cited by 18
Nitrinergic and peptidergic innervations and their inter-relationships in human colon
Gaumnitz, E. A., Sweet, M. A., Sengupta, A., et al. (1995) · Neuropeptides · doi:10.1016/0143-4179(95)90050-0 · Cited by 18
Richardson, J., Forsyth, L. M. G., Brown, C. G. D., et al. (1998) · Veterinary Research Communications · doi:10.1023/a:1005983111138 · Cited by 18
“…showed that activated bovine macrophages can produce NO and that NO, derived from S-nitroso-N-acetyl-dl -penicillamine, a well-documented producer of NO (Ignarro et al., 1981), prevents T. annulata trophozoite-infected cells transforming into macroschizont-infected cell lines (Visser et al., 1995).”
Background́bert, D. H., Xiang, J.-X., & Lam, J. Y. T. (1997) · Circulation · doi:10.1161/01.cir.95.5.1308 · Cited by 18
Vasodilators during cerebral aneurysm surgery
Abe, K. (1993) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03009775 · Cited by 18
Bower, E. A., & Law, A. C. K. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13489.x · Cited by 18
Walsh, D. B., Zwolak, R. M., McDaniel, M. D., et al. (1990) · Journal of Vascular Surgery · doi:10.1016/0741-5214(90)90070-q · Cited by 18
The antithrombotic effects of organic nitrates
Stamler, J. S., & Loscalzo, J. (1991) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(91)90073-n · Cited by 18
Use of nitrates in ischemic heart disease
Abrams, J. (1992) · Current Problems in Cardiology · doi:10.1016/0146-2806(92)90008-c · Cited by 18
Possible involvement of nitroglycerin converting step in nitroglycerin tolerance
Hasegawa, K., Taniguchi, T., Takakura, K., Goto, Y., & Muramatsu, I. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00171-x · Cited by 18
Moderation of Anal Sphincter Tone With Nitric Oxide Agonists and Antagonists
Hechtman, H. B. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430190097023 · Cited by 18
Clinical Relevance of Nitrate Tolerance
Silber, S. (1985) · International Böhringer Mannheim symposia · doi:10.1007/978-3-642-70234-1_18 · Cited by 18
Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
Pearson, R. J., & Butler, A. R. (2021) · Molecules · doi:10.3390/molecules26216581 · Cited by 18
“This work built on studies by others in the 1970s and 1980s, who showed that GTN’s activity was the result of NO generated in vascular smooth muscle [20,38].”
MethodNitroglycerin: a comprehensive review in cancer therapy
Meunier, M., Yammine, A., Bettaı̈eb, A., & Plenchette, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05838-5 · Cited by 19
“NO-released by NTG is known as a direct activator of soluble guanylyl cyclase (sGC), which activates the production of guanosine monophosphate cyclic (GMPc) and ultimately results in a signaling pathway that causes vascular smooth muscle relaxation [5].”
BackgroundApplication of nitric oxide in drug discovery and development
Bryan, N. S. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.613933 · Cited by 18
“As early as 1981, Ignarro’s group demonstrated that the bioactivities of certain pharmacological nitrogen oxide (NOx) donors were attributed to reactions with cellular thiols [68], which is several years before making the observation that NO is actually synthesized endogenously in mammalian cells.”
BackgroundSynthesis ofS-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines
Shah, S. U., Socha, M., Fries, I., et al. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1122676 · Cited by 17
“, GSNO offers significant protection to myocardial ischemia and SNAP is a powerful vasodilator (Ignarro et al., 1981)].”
BackgroundFethi Bedioui, A., Ismail, A., & Griveau, S. (2018) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2018.04.014 · Cited by 18
Parodi, O., Chiara, B. C. D., Baldassarre, D., et al. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.08.017 · Cited by 17
“Sulphydryl-containing compounds, like cysteine and GSH, are required for activation of soluble guanylate cyclase by biotransformation to vasoactive nitric oxide [33].”
BackgroundTan, C. S., & Yam, M. F. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1481-9 · Cited by 17
García-Bravo, A., Suárez-Hernández, D., Ruiz-Fernández, M. Á., et al. (2005) · Spinal Cord · doi:10.1038/sj.sc.3101846 · Cited by 17
Pegylated hemoglobins mechanisms to avoid vasoconstriction and maintain perfusion
Cabrales, P., & Friedman, J. M. (2007) · Transfusion Alternatives in Transfusion Medicine · doi:10.1111/j.1778-428x.2007.00090.x · Cited by 17
Blood vessel adaptation to gravity in a semi-arboreal snake
Conklin, D. J., Lillywhite, H. B., Olson, K. R., et al. (1996) · Journal of Comparative Physiology B · doi:10.1007/bf00387512 · Cited by 17
Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells
Liu, X., Abernethy, D. R., & Andrawis, N. S. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01172-7 · Cited by 17
Gong, F., Shiraishi, H., Kikuchi, Y., et al. (2000) · Pediatrics International · doi:10.1046/j.1442-200x.2000.01226.x · Cited by 17
Akhter, S., Green, J. R., Root, P. D., et al. (2003) · Nitric Oxide · doi:10.1016/s1089-8603(03)00031-4 · Cited by 17
Al-Mustafa, A. H., Sies, H., & Stahl, W. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00388-2 · Cited by 17
Bilzer, M., Paumgartner, G., & Gerbes, A. L. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90454-9 · Cited by 17
Hypoxia Increases Vasodilator Release From Internal Mammary Artery and Saphenous Vein Grafts
Pearson, P. J., Évora, P. R. B., Dışçıgıl, B., et al. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00096-4 · Cited by 17
“The active component of this relaxing factor is the nitric oxide radical [4], which also is the active metabolite of nitrovasodilators such as sodium nitroprusside and nitroglycerin [5].”
BackgroundHarohalli, K., Petersen, C. E., Ha, C., Feix, J. B., & Bhagavan, N. V. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256578 · Cited by 16
Nitrate tolerance in heart failure: Differential venous, pulmonary and systemic arterial effects
Makhoul, N., Dakak, N., Flugelman, M. Y., Merdler, A., Shefer, A., Schneeweiss, A., Halon, D. A., & Lewis, B. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91307-r · Cited by 17
Vasu, D., Do, H. T., Li, H., Hardy, C. D., Awasthi, A., Poulos, T. L., & Silverman, R. B. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00782 · Cited by 17
Accurate Nitric Oxide Measurements from Donors in Cell Media: Identification of Scavenging Agents
Harding, J. L., & Reynolds, M. M. (2014) · Analytical Chemistry · doi:10.1021/ac403174e · Cited by 16
Heunisch, F., Chaykovska, L., von Einem, G. F., et al. (2017) · Medicine · doi:10.1097/md.0000000000006065 · Cited by 16
“One of the main reasons of hypoxia is a vasoconstriction caused by CM-induced decrease of nitric oxide (NO) concentration.([12,13]) Asymmetric dimethylarginine (ADMA) as an inhibitor of the endogenous NO production is an important component of this pathway.”
BackgroundHelm, M. M., McGinnis, G. R., & Basu, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126294 · Cited by 17
“In animal models, organic nitrates induced vasodilation by stimulating cyclic guanosine monophosphate (cGMP) accumulation and relaxing vascular smooth muscle [72].”
BackgroundVasu, D., Li, H., Hardy, C. D., Poulos, T. L., & Silverman, R. B. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116878 · Cited by 17
Potential Benefits of Peroxynitrite
Nossaman, B. D., & Kadowitz, P. J. (2008) · The Open Pharmacology Journal · doi:10.2174/1874143600802010031 · Cited by 15
Self-citationHwang, S., Cha, W., & Meyerhoff, M. E. (2007) · Electroanalysis · doi:10.1002/elan.200704053 · Cited by 16
Jia, L., Pei, R., Lin, M., & Yang, X. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00079-5 · Cited by 16
Fazzari, M., Woodcock, S. R., Rowart, P., Ricart, K. C., Lancaster, J. R., Patel, R. P., Vitturi, D. A., Freeman, B. Α., & Schopfer, F. J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101913 · Cited by 16
“For example, NTG undergoes diverse chemical reactions with heme proteins and oxidoreductases to yield NO2− and Snitrosothiols [33,40].”
BackgroundSi, M.-L., & Lee, T. J.-F. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046854 · Cited by 16
“The relaxation induced by sodium nitroprusside, which is known to release NO upon entering the smooth muscle cells (Ignarro et al., 1981) was not affected by lead, indicating that lead blockade of nitrergic neurogenic vasodilation induced by nicotine and choline was not due to blockade of NO-cGMP…”
BackgroundCalvillo, L., Masson, S., Salio, M., et al. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026182404805 · Cited by 16
Salvemini, D., Pistelli, A., & Mollace, V. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13587.x · Cited by 16
Karoon, P., Knight, G. E., & Burnstock, G. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.927bd.x · Cited by 16
“SNP spontaneously releases NO in aqueous solution, which subsequently diffuses into smooth muscle and causes nonreceptor-mediated relaxation by stimulation of cGMP (Ignarro et al. 1981).”
BackgroundDinh‐Xuan, A. T., HIGENBOTTAM, T. W., & Wallwork, J. L. (1992) · Angiology · doi:10.1177/000331979204300410 · Cited by 16
Ray, S. A., Buckenham, T. M., Belli, A.-M., et al. (1997) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(97)80209-2 · Cited by 16
Manning, J. J., Wirz, A. A., & McColl, K. E. L. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701452332 · Cited by 15
“Neuronally released NO and NO donors such as nitrosothiols relax the body of the oesophagus, the lower oesophageal sphincter (LOS) [6] and also the body of the stomach [7].”
BackgroundNitric oxide enhances expression of raf kinase inhibitor protein in keratinocytes
Tsao, D., Yu, H., & Chang, H. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00811.x · Cited by 16
Bauer, J. A., & Fung, H. (1991) · Pharmaceutical Research · doi:10.1023/a:1015824417569 · Cited by 16
The Reactions of 3,5-Dibromo-4-nitrosobenzenesulfonate and its Biological Applications
Ichimori, K., Arroyo, C. M., Prónai, L., et al. (1993) · Free Radical Research Communications · doi:10.3109/10715769309056s129 · Cited by 16
Adrenotensin: An adrenomedullin gene product contracts pulmonary blood vessels
Gümüşel, B., Chang, J., Hao, Q., et al. (1996) · Peptides · doi:10.1016/0196-9781(95)02150-7 · Cited by 16
Self-citationRELAXANT EFFECTS OF BRAIN NATRIURETIC PEPTIDE ON GUINEA‐PIG TRACHEAL SMOOTH MUSCLE
Takagi, K., & Araki, N. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01676.x · Cited by 16
Nitrate resistance and tolerance: Potential limitations in the treatment of congestive heart failure
Elkayam, U., Mehra, A., Shotan, A., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90601-t · Cited by 16
Iesaki, T., Gupte, S. A., & Wolin, M. S. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1027 · Cited by 16
Ishihata, A., Katano, Y., Nakamura, M., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00575-0 · Cited by 16
Hemodynamic and sympathetic effects of fenoldopam and sodium nitroprusside
Yakazu, Y., Iwasawa, K., Narita, H., Kindscher, J. D., Benson, K. T., & Goto, H. (2001) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2001.450920.x · Cited by 16
Provost, P., Tremblay, J., & Merhi, Y. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1806 · Cited by 16
Kodama, K., Adachi, H., Mori, N., et al. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90528-2 · Cited by 16
Tejedor, C., Lorente, J. A., Delgado, M. A., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200211000-00015 · Cited by 16
“Snitrosothiols have recently been identified in vivo (38, 39, 47) and appear to be more potent smooth muscle relaxants than nitric oxide itself (42, 48–51).”
BackgroundRenowden, S. A., Edwards, D. H., & Griffith, T. M. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14339.x · Cited by 16
Soares-da-Silva, P., & Caramona, M. M. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05297.x · Cited by 16
The chemistry of hydropersulfides (RSSH) as related to possible physiological functions
Fukuto, J. M. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109659 · Cited by 18
Liebeskind, S., Korth, H., de GROOT, H., & Kirsch, M. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b801583j · Cited by 15
Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats
Zhou, Q., Sun, Y., Tan, W., Liu, X., Qian, Y., Ma, X., Wang, T., Wang, X., & Gao, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176777 · Cited by 15
Neubauer, R., Wölkart, G., Opelt, M., Schwarzenegger, C., Hofinger, M., Neubauer, A., Kollau, A., Schmidt, K., Schrammel, A., & Mayer, B. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.021 · Cited by 15
“Besides the non-enzymatic reaction of GTN with cysteine [1, 2] or ascorbate [3], several enzymes were proposed to catalyze GTN bioactivation, in particular GSH-S-transferase [4, 5], cytochrome P450 [6, 7], cytochrome P450 reductase [8] and xanthine oxidase, which exhibits nitrite reductase activity at low oxygen tensi…”
BackgroundMethodNortcliffe, A., Fleming, I. N., Botting, N. P., & O’Hagan, D. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.09.004 · Cited by 16
Šimko, F., Matusková, J., Luptak, I., et al. (2007) · Physiological Research · doi:10.33549/physiolres.931394 · Cited by 15
Watanabe, H., Kakihana, M., Ohtsuka, S., et al. (1998) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.62.353 · Cited by 15
Sato, S., Suzuki, A. K., Nakajima, Y., et al. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200002000-00023 · Cited by 15
Izumi, H., Tanaka, Y., Okada, Y., et al. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02139-6 · Cited by 15
Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries
Schini, V. B., Dewey, J., & Vanhoutte, P. M. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90336-y · Cited by 15
Mechanisms of Nitrite Reduction in Ischemia in the Cardiovascular System
Webb, A., & Ahluwalia, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00017-4 · Cited by 15
Yamazaki, A., & Birnboim, H. C. (1995) · Leukemia Research · doi:10.1016/0145-2126(94)00125-t · Cited by 15
Novel mode of nitric oxide neurotransmission mediated via S‐nitroso‐cysteinyl‐glycine
Salt, T. E., Zhang, H., Mayer, B., Benz, B., Binns, K. E., & Do, K. Q. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00285.x · Cited by 15
Vascular endothelium and nitric oxide in childhood hypertension
Goonasekera, C. D. A., & Dillon, M. J. (1998) · Pediatric Nephrology · doi:10.1007/s004670050527 · Cited by 15
Adding, C., Bannenberg, G. L., & Gustafsson, L. E. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01435.x · Cited by 15
A possible role of S-nitrosothiols at the nitrergic relaxations in the mouse corpus cavernosum
Göçmen, C., Seçilmiş, A., Uçar, P., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00703-1 · Cited by 15
Dumas, M., Dumas, J., Rochette, L., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15237.x · Cited by 15
Fung, H. L. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04141.x · Cited by 15
Identification of nitroglycerin-induced cysteine modifications of pro-matrix metalloproteinase-9
Krishnatry, A. S., Kamei, T., Wang, H., Qu, J., & Fung, H. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5118 · Cited by 9
Metadata
- Authors
- Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1981-09
- Volume
- 218
- Issue
- 3
- Pages
- 739-749
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1907994445
- Cited by
- 1,633
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 6 · 2020: 8 · 2019: 14 · 2018: 23 · 2017: 10 · 2016: 15 · 2015: 16 · 2014: 14 · 2013: 16 · 2012: 27
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- vasorelaxation, organic nitrates, nitrite, sodium nitroprusside, nitric oxide, S-nitrosothiols, guanylate cyclase activation, cyclic GMP, nitroglycerin, isosorbide dinitrate, PETN, amyl nitrite, sodium nitrite, sulfhydryl groups, coronary arteries
- MeSH terms
- Animals, Biotransformation, Cats, Cattle, Coronary Vessels, Enzyme Activation, Female, Ferricyanides, Guanylate Cyclase, Hemodynamics, Male, Nitrates, Nitric Oxide, Nitrites, Nitroprusside, Nitroso Compounds, Vasodilator Agents, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review